Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
neoadjuvant chemoradiation therapy
OTHER
2 trials
Sponsors
Henan Cancer Hospital
, Changhai Hospital
Conditions
Esophageal Squamous Cell Carcinoma
Rectal Cancer
Phase 2
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer
Not yet recruiting
NCT07134218
Changhai Hospital
Rectal Cancer
Start: 2025-10-31
End: 2027-10-31
Target: 180
Updated: 2025-08-21
Phase 3
Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)
Recruiting
NCT04138212
Henan Cancer Hospital
Esophageal Squamous Cell Carcinoma
Start: 2019-10-22
End: 2028-12-21
Target: 456
Updated: 2022-08-09
Related Papers
Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study).
2020-06-27
18 citations
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903).
2020-04-15
12 citations